AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 173 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 2.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $302,000 | -41.4% | 8,675 | -58.7% | 0.09% | -19.6% |
| Q3 2016 | $515,000 | +2.6% | 21,001 | 0.0% | 0.11% | -14.4% |
| Q2 2016 | $502,000 | +2.2% | 21,001 | 0.0% | 0.12% | -17.8% |
| Q1 2016 | $491,000 | +31.3% | 21,001 | +123.0% | 0.15% | +53.5% |
| Q3 2015 | $374,000 | -60.0% | 9,416 | -30.5% | 0.10% | -43.8% |
| Q2 2015 | $935,000 | +40.8% | 13,542 | +11.4% | 0.18% | +50.4% |
| Q1 2015 | $664,000 | -23.4% | 12,154 | -40.2% | 0.12% | -15.8% |
| Q4 2014 | $867,000 | +33.6% | 20,335 | 0.0% | 0.14% | +67.5% |
| Q3 2014 | $649,000 | +164.9% | 20,335 | +72.0% | 0.08% | +219.2% |
| Q2 2014 | $245,000 | +7.0% | 11,822 | 0.0% | 0.03% | 0.0% |
| Q1 2014 | $229,000 | -20.2% | 11,822 | 0.0% | 0.03% | -27.8% |
| Q4 2013 | $287,000 | -38.7% | 11,822 | -45.7% | 0.04% | -52.6% |
| Q3 2013 | $468,000 | +40.5% | 21,772 | +45.5% | 0.08% | +15.2% |
| Q2 2013 | $333,000 | – | 14,967 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bleichroeder LP | 1,299,994 | $12,220,000 | 2.19% |
| Camber Capital Management LP | 8,780,000 | $82,532,000 | 2.18% |
| Palo Alto Investors LP | 3,003,875 | $28,236,000 | 1.55% |
| ARMISTICE CAPITAL, LLC | 4,120,000 | $38,728,000 | 1.40% |
| Permanens Capital L.P. | 359,311 | $3,378,000 | 1.17% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 31,582 | $297,000 | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 348,000 | $3,271,000 | 0.20% |
| Teza Capital Management LLC | 20,300 | $191,000 | 0.11% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 767,135 | $7,211,000 | 0.08% |
| Livforsakringsbolaget Skandia, Omsesidigt | 38,800 | $365,000 | 0.04% |